Trials / Completed
CompletedNCT00360295
A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 153 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical efficacy and safety in patients with mild or moderate community-acquired pneumonia receiving a dose of 2 g of azithromycin in the SR formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin SR |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2006-08-04
- Last updated
- 2008-05-20
Locations
54 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00360295. Inclusion in this directory is not an endorsement.